Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] γ2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice

Brain Research

Volumn 1271, Issue , 2009, Pages 36-48

  Chang, Min ^a   Li, Wei ^a   Peng, Ya li ^a   Gao, Ya hu ^a   Yao, Jia ^a   Han, Ren wen ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Tyr6 2 MSH(6 12); Hyperalgesia; Mas related gene C (MrgC); NMDA receptor; Nociceptin orphanin FQ (N OFQ); Nociceptive behavior

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; ANALGESIC AGENT; DEXTRO 2 AMINO 5 PHOSPHONOVALERIC ACID; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NEUROKININ A [4-10][5 TYROSINE 6,8,9 DEXTRO TRYPTOPHAN 10 LYSINE]; NOCICEPTIN; NOCICEPTIN RECEPTOR ANTAGONIST; TYROSINE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; MALE; MOLECULAR INTERACTION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-MSH; HORMONES; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MICE; NEUROKININ A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NOCICEPTORS; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; SPINAL CORD;

MUS;

EID: 65149084087     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.03.041     Document Type: Article

References (83)

1. Aanonsen L.M., Lei S., and Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain 41 (1990) 309-321
2. Bender E., Buist A., Jurzak M., Langlois X., Baggerman G., Verhasselt P., Ercken M., Guo H.Q., Wintmolders C., Van W.I., Van O.I., Schoofs L., and Luyten W. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8573-8578
3. Bredt D.S., Hwang P.M., and Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 (1990) 768-770
4. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., and Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347 (1994) 284-288
5. Cai M., Chen T., Quirion R., and Hong Y. The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing. Eur. J. Neurosci. 26 (2007) 1128-1138
6. Chang M., Peng Y.L., Dong S.L., Han R.W., Li W., Yang D.J., Chen Q., and Wang R. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor. Regul. Pept. 130 (2005) 116-122
7. Chen T., Cai Q., and Hong Y. Intrathecal sensory neuron-specific receptor agonists bovine adrenal medulla 8-22 and (Tyr6)-gamma2-MSH-6-12 inhibit formalin-evoked nociception and neuronal Fos-like immunoreactivity in the spinal cord of the rat. Neuroscience 141 (2006) 965-975
8. Chen T., Hu Z., Quirion R., and Hong Y. Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology 54 (2008) 796-803
9. Choi S.S., and Lahn B.T. Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception. Genome Res. 13 (2003) 2252-2259
10. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 (1993) 259-285
11. Courteix C., Coudore-Civiale M.A., Privat A.M., Pelissier T., Eschalier A., and Fialip J. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 110 (2004) 236-245
12. Cox P.J., Pitcher T., Trim S.A., Bell C.H., Qin W., and Kinloch R.A. The effect of deletion of the orphan G - protein coupled receptor (GPCR) gene MrgE on pain-like behaviours in mice. Mol. Pain 4 (2008) 2
13. Dong X., Han S., Zylka M.J., Simon M.I., and Anderson D.J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106 (2001) 619-632
14. Fairbanks C.A. Spinal delivery of analgesics in experimental models of pain and analgesia. Adv. Drug Deliv. Rev. 55 (2003) 1007-1041
15. Gamse R., and Saria A. Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice. Neurosci. Lett. 70 (1986) 143-147
16. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14 (1991) 60-67
17. Garthwaite J., Charles S.L., and Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336 (1988) 385-388
18. Grazzini E., Puma C., Roy M.O., Yu X.H., O'Donnell D., Schmidt R., Dautrey S., Ducharme J., Perkins M., Panetta R., Laird J.M., Ahmad S., and Lembo P.M. Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7175-7180
19. Gustafson E.L., Maguire M., Campanella M., Tarozzo G., Jia Y., Dong X.W., Laverty M., Murgolo N., Priestley T., Reggiani A., Monsma F., and Beltramo M. Regulation of two rat mas-related genes in a model of neuropathic pain. Brain Res. Mol. Brain Res. 142 (2005) 58-64
20. Hager U.A., Hein A., Lennerz J.K., Zimmermann K., Neuhuber W.L., and Reeh P.W. Morphological characterization of rat Mas-related G-protein-coupled receptor C and functional analysis of agonists. Neuroscience 151 (2008) 242-254
21. Han S.K., Dong X., Hwang J.I., Zylka M.J., Anderson D.J., and Simon M.I. Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14740-14745
22. Hao J.X., Xu I.S., Wiesenfeld-Hallin Z., and Xu X.J. Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain 76 (1998) 385-393
23. Hara N., Minami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., and Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br. J. Pharmacol. 121 (1997) 401-408
24. Honan S.A., and McNaughton P.A. Sensitisation of TRPV1 in rat sensory neurones by activation of SNSRs. Neurosci. Lett. 422 (2007) 1-6
25. Hong Y., Dai P., Jiang J., and Zeng X. Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain - potential function of a novel receptor. Br. J. Pharmacol. 141 (2004) 423-430
26. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
27. Inoue M., Shimohira I., Yoshida A., Zimmer A., Takeshima H., Sakurada T., and Ueda H. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J. Pharmacol. Exp. Ther. 291 (1999) 308-313
28. Inoue M., Kawashima T., Takeshima H., Calo G., Inoue A., Nakata Y., and Ueda H. In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. J. Pharmacol. Exp. Ther. 305 (2003) 495-501
29. Kamohara M., Matsuo A., Takasaki J., Kohda M., Matsumoto M., Matsumoto S., Soga T., Hiyama H., Kobori M., and Katou M. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides. Biochem. Biophys. Res. Commun. 330 (2005) 1146-1152
30. King M.A., Rossi G.C., Chang A.H., Williams L., and Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223 (1997) 113-116
31. Kitto K.F., Haley J.E., and Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148 (1992) 1-5
32. Knowles R.G., and Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298 Pt 2 (1994) 249-258
33. Kolhekar R., Meller S.T., and Gebhart G.F. Characterization of the role of spinal N-methyl-d-aspartate receptors in thermal nociception in the rat. Neuroscience 57 (1993) 385-395
34. Komatsu T., Sakurada C., Sasaki M., Sanai K., Tsuzuki M., Bagetta G., Sakurada S., and Sakurada T. Extracellular signal-regulated kinase (ERK) and nitric oxide synthase mediate intrathecal morphine-induced nociceptive behavior. Neuropharmacology 52 (2007) 1237-1243
35. Lembo P.M., Grazzini E., Groblewski T., O'Donnell D., Roy M.O., Zhang J., Hoffert C., Cao J., Schmidt R., Pelletier M., Labarre M., Gosselin M., Fortin Y., Banville D., Shen S.H., Strom P., Payza K., Dray A., Walker P., and Ahmad S. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 5 (2002) 201-209
36. Malmberg A.B., and Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54 (1993) 291-300
37. Matsumura H., Sakurada T., Hara A., Sakurada S., and Kisara K. Characterization of the hyperalgesic effect induced by intrathecal injection of substance P. Neuropharmacology 24 (1985) 421-426
38. Meller S.T., and Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52 (1993) 127-136
39. Meller S.T., Dykstra C., and Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-d-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214 (1992) 93-96
40. Meller S.T., Pechman P.S., Gebhart G.F., and Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 50 (1992) 7-10
41. Meller S.T., Cummings C.P., Traub R.J., and Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 60 (1994) 367-374
42. Meller S.T., Dykstra C., and Gebhart G.F. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-d-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience 71 (1996) 327-335
43. Mjellem N., Lund A., and Hole K. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice. Neuropharmacology 32 (1993) 591-595
44. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
45. Moochhala S.M., and Sawynok J. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization. Br. J. Pharmacol. 82 (1984) 381-388
46. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., and Hart S.L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102 (1991) 198-202
47. Nakamura-Craig M., and Gill B.K. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci. Lett. 124 (1991) 49-51
48. Nazzaro C., Rizzi A., Salvadori S., Guerrini R., Regoli D., Zeilhofer H.U., and Calo G. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides 28 (2007) 663-669
49. 2-induced hyperalgesia in conscious mice. Brain Res. 677 (1995) 138-144
50. 2 of nociceptin/orphanin FQ receptor. Regul. Pept. 134 (2006) 75-81
51. Raigorodsky G., and Urca G. Intrathecal N-methyl-d-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res. 422 (1987) 158-162
52. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., and Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport 7 (1996) 1369-1372
53. Rizzi A., Nazzaro C., Marzola G.G., Zucchini S., Trapella C., Guerrini R., Zeilhofer H.U., Regoli D., and Calo' G. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences. Pain 124 (2006) 100-108
54. Robas N., Mead E., and Fidock M. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J. Biol. Chem. 278 (2003) 44400-44404
55. Sakurada T., Manome Y., Tan-No K., Sakurada S., and Kisara K. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-d-aspartate in mice. Br. J. Pharmacol. 101 (1990) 307-310
56. Sakurada T., Sugiyama A., Sakurada C., Tanno K., Sakurada S., Kisara K., Hara A., and Abiko Y. Involvement of nitric oxide in spinally mediated capsaicin- and glutamate-induced behavioural responses in the mouse. Neurochem. Int. 29 (1996) 271-278
57. 1 receptors in nociceptin-induced hyperalgesia in mice. Brain Res. 841 (1999) 85-92
58. 1 receptors. Br. J. Pharmacol. 127 (1999) 1712-1718
59. Sakurada S., Orito T., Sakurada C., Sato T., Hayashi T., Mobarakeh J.I., Yanai K., Onodera K., Watanabe T., and Sakurada T. Possible involvement of tachykinin NK(1) and NMDA receptors in histamine-induced hyperalgesia in mice. Eur. J. Pharmacol. 434 (2002) 29-34
60. Sakurada T., Watanabe C., Okuda K., Sugiyama A., Moriyama T., Sakurada C., Tan-No K., and Sakurada S. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors. Brain Res. Mol. Brain Res. 98 (2002) 111-118
61. Sakurada S., Watanabe H., Mizoguchi H., Yonezawa A., Orito T., Katsuyama S., Kuramasu A., Sakurada C., Yanai K., and Sakurada T. Involvement of the histaminergic system in the nociceptin-induced pain-related behaviors in the mouse spinal cord. Pain 112 (2004) 171-182
62. Sakurada T., Komatsu T., and Sakurada S. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 26 (2005) 801-809
63. Salter M., Strijbos P.J., Neale S., Duffy C., Follenfant R.L., and Garthwaite J. The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience 73 (1996) 649-655
64. Schaible H.G., and Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain 55 (1993) 5-54
65. Schuligoi R., Amann R., Angelberger P., and Peskar B.A. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci. Lett. 224 (1997) 136-138
66. Schulz S., Schreff M., Nuss D., Gramsch C., and Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. NeuroReport 7 (1996) 3021-3025
67. Shinohara T., Harada M., Ogi K., Maruyama M., Fujii R., Tanaka H., Fukusumi S., Komatsu H., Hosoya M., Noguchi Y., Watanabe T., Moriya T., Itoh Y., and Hinuma S. Identification of a G protein-coupled receptor specifically responsive to beta-alanine. J. Biol. Chem. 279 (2004) 23559-23564
68. Takahasi K., Sakurada T., Sakurada S., Kuwahara H., Yonezawa A., Ando R., and Kisara K. Behavioural characterization of substance P-induced nociceptive response in mice. Neuropharmacology 26 (1987) 1289-1293
69. Tan-No K., Taira A., Wako K., Niijima F., Nakagawasai O., Tadano T., Sakurada C., Sakurada T., and Kisara K. Intrathecally administered spermine produces the scratching, biting and licking behaviour in mice. Pain 86 (2000) 55-61
70. Tan-No K., Esashi A., Nakagawasai O., Niijima F., Tadano T., Sakurada C., Sakurada T., Bakalkin G., Terenius L., and Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism. Brain Res. 952 (2002) 7-14
71. Tan-No K., Esashi A., Nakagawasai O., Niijima F., Sakurada C., Sakurada T., Bakalkin G., Terenius L., and Tadano T. Nociceptive behavior induced by poly-l-lysine and other basic compounds involves the spinal NMDA receptors. Brain Res. 1008 (2004) 49-53
72. Tsuda M., Ueno S., and Inoue K. In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br. J. Pharmacol. 127 (1999) 449-456
73. Urca G., and Raigorodsky G. Behavioral classification of excitatory amino acid receptors in mouse spinal cord. Eur. J. Pharmacol. 153 (1988) 211-220
74. Vincent S.R., and Hope B.T. Neurons that say NO. Trends Neurosci. 15 (1992) 108-113
75. Wang Z., Takahashi T., Saito Y., Nagasaki H., Ly N.K., Nothacker H.P., Reinscheid R.K., Yang J., Chang J.K., Shichiri M., and Civelli O. Salusin beta is a surrogate ligand of the mas-like G protein-coupled receptor MrgA1. Eur. J. Pharmacol. 539 (2006) 145-150
76. Watanabe C., Orito T., Watanabe H., Mizoguchi H., Yonezawa A., Yanai K., Mobarakeh J.I., Onodera K., Sakurada T., and Sakurada S. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors. Eur. J. Pharmacol. 581 (2008) 54-63
77. Wick M.J., Minnerath S.R., Roy S., Ramakrishnan S., and Loh H.H. Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res. Mol. Brain Res. 32 (1995) 342-347
78. Wiesenfeld-Hallin Z., Hokfelt T., Lundberg J.M., Forssmann W.G., Reinecke M., Tschopp F.A., and Fischer J.A. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci. Lett. 52 (1984) 199-204
79. Xu X.J., Hao J.X., and Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport 7 (1996) 2092-2094
80. Yamamoto T., Nozaki-Taguchi N., and Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 81 (1997) 249-254
81. Zeilhofer H.U., and Calo G. Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy?. J. Pharmacol. Exp. Ther. 306 (2003) 423-429
82. Zeng X., Huang H., and Hong Y. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn. Brain Res. 1028 (2004) 170-179
83. Zylka M.J., Dong X., Southwell A.L., and Anderson D.J. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10043-10048